Advanced
  Home Compare Reports

Comparison with Similar Reports

Blood Culture Tests Market by Method (Automated, Conventional), Product (Consumable, Media, Instruments), Technology (PCR, Microarray, Proteomic), App...

by Method (Automated, Conventional), Product (Consumable, Media, Instruments), Technology (PCR, Microarray, Proteomic), Application (Bacteremia, Mycobacterial), End User (Hospital, Academic Research) - Global Forecast to 2025

Publisher:        MarketsandMarkets

# of Pages:        183

Rating: 

1 User License $4,950

Publication Date:  February, 2021

Price:       $4,950 / User License




TABLE OF CONTENTS

 

1              INTRODUCTION                28

1.1          OBJECTIVES OF THE STUDY          28

1.2          MARKET DEFINITION      29

1.2.1      MARKETS COVERED        30

1.2.2      YEARS CONSIDERED FOR THE STUDY        31

1.3          CURRENCY          31

1.4          LIMITATIONS     31

1.5          STAKEHOLDERS 32

1.6          SUMMARY OF CHANGES              32

2              RESEARCH METHODOLOGY         34

2.1          RESEARCH DATA               34

FIGURE 1             RESEARCH DESIGN          34

2.1.1      SECONDARY DATA           35

2.1.1.1   Secondary sources          35

2.1.2      PRIMARY DATA 35

2.1.2.1   Key data from primary sources  36

FIGURE 2             BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION           36

2.2          MARKET SIZE ESTIMATION          37

2.2.1      BOTTOM-UP APPROACH              37

FIGURE 3             MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH      37

2.2.2      GROWTH FORECAST       37

2.3          MARKET BREAKDOWN & DATA TRIANGULATION              38

FIGURE 4             DATA TRIANGULATION METHODOLOGY               38

2.4          ASSUMPTIONS FOR THE STUDY 39

3              EXECUTIVE SUMMARY  40

FIGURE 5             BLOOD CULTURE TESTS MARKET, BY PRODUCT,

2020 VS. 2025 (USD MILLION)     40

FIGURE 6             BLOOD CULTURE TESTS MARKET, BY METHOD,

2020 VS. 2025 (USD MILLION)     41

FIGURE 7             BLOOD CULTURE TESTS MARKET, BY APPLICATION,

2020 VS. 2025 (USD MILLION)     41

FIGURE 8             BLOOD CULTURE TESTS MARKET, BY END USER,

2020 VS. 2025 (USD MILLION)     42

FIGURE 9             BLOOD CULTURE TESTS MARKET, BY REGION, 2020 VS. 2025 (USD MILLION)         43

4              PREMIUM INSIGHTS       44

4.1          BLOOD CULTURE TESTS MARKET OVERVIEW        44

FIGURE 10           RISING PREVALENCE OF INFECTIOUS DISEASES TO DRIVE MARKET GROWTH        44

4.2          NORTH AMERICA: BLOOD CULTURE TESTS MARKET, BY METHOD & COUNTRY (2019)        45

FIGURE 11           CONVENTIONAL/MANUAL BLOOD CULTURE METHODS SEGMENT ACCOUNTED FOR THE LARGEST MARKET SHARE IN 2019   45

4.3          BLOOD CULTURE TESTS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES           46

FIGURE 12           ASIA PACIFIC COUNTRIES TO REGISTER HIGH GROWTH DURING THE FORECAST PERIOD 46

5              MARKET OVERVIEW       47

5.1          INTRODUCTION                47

5.2          MARKET DYNAMICS       48

FIGURE 13           BLOOD CULTURE TESTS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES      48

5.2.1      DRIVERS               48

5.2.1.1   Growing number of sepsis cases and high cost of treatment        48

TABLE 1                US: FIVE MOST EXPENSIVE CONDITIONS TREATED IN HOSPITALS               49

5.2.1.2   Rising geriatric population            49

TABLE 2                GERIATRIC POPULATION: KEY STATISTICS             49

5.2.1.3   High incidence of bloodstream infections             49

5.2.1.4   Growing demand for rapid diagnostic techniques             50

5.2.1.5   High prevalence of infectious diseases   50

5.2.2      RESTRAINTS       50

5.2.2.1   High cost of automated instruments       50

5.2.2.2   Lack of trained laboratory technicians     51

5.2.3      OPPORTUNITIES               51

5.2.3.1   Emerging economies      51

5.2.3.2   Identification of antibiotic-resistant microorganisms        51

5.2.4      CHALLENGES      52

5.2.4.1   Market cannibalization  52

5.2.4.2   Survival of new entrants               52

5.2.5      TRENDS                52

5.2.5.1   Laboratory automation for increased efficiency and accurate diagnosis  52

5.3          VALUE CHAIN ANALYSIS               53

FIGURE 14           MAJOR VALUE IS ADDED DURING THE MANUFACTURING AND ASSEMBLY PHASES           53

5.4          ECOSYSTEM ANALYSIS OF THE BLOOD CULTURE PRODUCTS MARKET       54

FIGURE 15           ECOSYSTEM ANALYSIS   54

5.5          COVID-19 IMPACT ON THE BLOOD CULTURE TESTS MARKET         54

6              BLOOD CULTURE TESTS MARKET, BY METHOD    55

6.1          INTRODUCTION                56

TABLE 3                BLOOD CULTURE TESTS MARKET, BY METHOD, 2018–2025 (USD MILLION)             56

6.2          CONVENTIONAL/MANUAL BLOOD CULTURE       56

6.2.1      CONVENTIONAL/MANUAL BLOOD CULTURE METHODS ACCOUNT FOR THE LARGER SHARE OF THE MARKET        56

TABLE 4                EXAMPLES OF CONVENTIONAL/MANUAL BLOOD CULTURE PRODUCTS  57

TABLE 5                CONVENTIONAL/MANUAL BLOOD CULTURE METHODS MARKET, BY REGION, 2018–2025 (USD MILLION)                57

6.3          AUTOMATED BLOOD CULTURE  58

6.3.1      AUTOMATED BLOOD CULTURE METHODS SEGMENT TO REGISTER THE HIGHEST GROWTH IN THE FORECAST PERIOD                58

TABLE 6                EXAMPLES OF AUTOMATED BLOOD CULTURE PRODUCTS             59

TABLE 7                AUTOMATED BLOOD CULTURE METHODS MARKET, BY REGION,

2018–2025 (USD MILLION)           59

7              BLOOD CULTURE TESTS MARKET, BY PRODUCT   60

7.1          INTRODUCTION                61

TABLE 8                BLOOD CULTURE TESTS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)           61

7.2          CONSUMABLES                61

TABLE 9                BLOOD CULTURE CONSUMABLES MARKET, BY TYPE,

2018–2025 (USD MILLION)           61

TABLE 10              BLOOD CULTURE CONSUMABLES MARKET, BY REGION,

2018–2025 (USD MILLION)           62

7.2.1      BLOOD CULTURE MEDIA               62

TABLE 11              EXAMPLES OF BLOOD CULTURE MEDIA  62

TABLE 12              BLOOD CULTURE MEDIA MARKET, BY TYPE, 2018–2025 (USD MILLION)   63

TABLE 13              BLOOD CULTURE MEDIA MARKET, BY REGION, 2018–2025 (USD MILLION)             63

7.2.1.1   Aerobic blood culture media       63

7.2.1.1.1               Aerobic blood culture media is the fastest-growing segment of the blood culture media market                63

TABLE 14              AEROBIC BLOOD CULTURE MEDIA MARKET, BY REGION,

2018–2025 (USD MILLION)           64

7.2.1.2   Pediatric aerobic blood culture media     64

7.2.1.2.1               This type of culture media is used to recover pathogens from the bloodstream of children           64

TABLE 15              PEDIATRIC AEROBIC BLOOD CULTURE MEDIA MARKET, BY REGION,

2018–2025 (USD MILLION)           65

7.2.1.3   Anaerobic blood culture media  65

7.2.1.3.1               Anaerobic microorganisms account for 1—17% of the positive blood cultures      65

TABLE 16              ANAEROBIC BLOOD CULTURE MEDIA MARKET, BY REGION,

2018–2025 (USD MILLION)           65

7.2.1.4   Mycobacterial blood culture media          66

7.2.1.4.1               Rising prevalence of tuberculosis to drive market growth              66

TABLE 17              MYCOBACTERIAL BLOOD CULTURE MEDIA MARKET, BY REGION,

2018–2025 (USD MILLION)           66

7.2.1.5   Fungi/yeast blood culture media              66

7.2.1.5.1               Fungi/yeast blood culture media is used to detect fungemia       66

TABLE 18              FUNGI/YEAST BLOOD CULTURE MEDIA MARKET, BY REGION,

2018–2025 (USD MILLION)           67

7.2.2      ASSAY KITS & REAGENTS              67

7.2.2.1   Reagents are key components of conventional blood culture tests           67

TABLE 19              EXAMPLES OF BLOOD CULTURE ASSAY KITS         67

TABLE 20              ASSAY KITS & REAGENTS MARKET, BY REGION, 2018–2025 (USD MILLION)            68

7.2.3      BLOOD CULTURE ACCESSORIES  68

7.2.3.1   Growing number of blood culture tests to support market growth           68

TABLE 21              EXAMPLES OF BLOOD CULTURE ACCESSORIES    68

TABLE 22              BLOOD CULTURE ACCESSORIES MARKET, BY REGION,

2018–2025 (USD MILLION)           69

7.3          INSTRUMENTS  69

TABLE 23              BLOOD CULTURE INSTRUMENTS MARKET, BY TYPE,

2018–2025 (USD MILLION)           69

7.3.1      AUTOMATED BLOOD CULTURE SYSTEMS               70

7.3.1.1   Automated blood culture systems is the largest & fastest-growing segment of the instruments market 70

TABLE 24              EXAMPLES OF AUTOMATED BLOOD CULTURE SYSTEMS 70

TABLE 25              AUTOMATED BLOOD CULTURE SYSTEMS MARKET, BY REGION,

2018–2025 (USD MILLION)           71

7.3.2      SUPPORTING LABORATORY EQUIPMENT              71

TABLE 26              SUPPORTING LABORATORY EQUIPMENT MARKET, BY TYPE,

2018–2025 (USD MILLION)           71

TABLE 27              SUPPORTING LABORATORY EQUIPMENT MARKET, BY REGION,

2018–2025 (USD MILLION)           72

7.3.2.1   Incubators          72

7.3.2.1.1               Incubators provide an optimal environment with respect to temperature, humidity, and oxygen level for microbial growth              72

TABLE 28              INCUBATORS MARKET, BY REGION, 2018–2025 (USD MILLION)   72

7.3.2.2   Colony counters               73

7.3.2.2.1               Colony counters increase direct image scanning and analysis capability   73

TABLE 29              COLONY COUNTERS MARKET, BY REGION, 2018–2025 (USD MILLION)     73

7.3.2.3   Microscopes      73

7.3.2.3.1               Favorable funding scenario for R&D in microscopy to drive market growth            73

TABLE 30              MICROSCOPES MARKET, BY REGION, 2018–2025 (USD MILLION)                74

7.3.2.4   Gram stainers    74

7.3.2.4.1               Gram staining offers relatively quicker results    74

TABLE 31              GRAM STAINERS MARKET, BY REGION, 2018–2025 (USD MILLION)            74

7.4          SOFTWARE & SERVICES 75

7.4.1      NEED FOR AUTOMATED SYSTEMS IN HOSPITAL-BASED LABORATORIES TO DRIVE MARKET GROWTH        75

TABLE 32              BLOOD CULTURE SOFTWARE & SERVICES MARKET, BY REGION,

2018–2025 (USD MILLION)           75

8              BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY           76

8.1          INTRODUCTION                77

TABLE 33              BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY,

2018-2025 (USD MILLION)            77

8.2          CULTURE-BASED TECHNOLOGIES              77

8.2.1      DRAWBACKS ASSOCIATED WITH TRADITIONAL CULTURE-BASED TECHNOLOGIES TO RESTRAIN MARKET GROWTH                77

TABLE 34              BLOOD CULTURE TESTS MARKET FOR CULTURE-BASED TECHNOLOGIES,

BY REGION, 2018-2025 (USD MILLION)   78

8.3          MOLECULAR TECHNOLOGIES      78

TABLE 35              BLOOD CULTURE TESTS MARKET FOR MOLECULAR TECHNOLOGIES,

BY TYPE, 2018-2025 (USD MILLION)          78

TABLE 36              BLOOD CULTURE TESTS MARKET FOR MOLECULAR TECHNOLOGIES,

BY REGION, 2018-2025 (USD MILLION)   79

8.3.1      MICROARRAYS  79

8.3.1.1   Microarrays is the largest & fastest-growing segment of the molecular technologies market        79

TABLE 37              BLOOD CULTURE TESTS MARKET FOR MICROARRAYS, BY REGION,

2018-2025 (USD MILLION)            79

8.3.2      PCR        80

8.3.2.1   PCR is used with genetic markers to analyze pathogens directly from whole blood samples          80

TABLE 38              BLOOD CULTURE TESTS MARKET FOR PCR, BY REGION,

2018-2025 (USD MILLION)            80

8.3.3      PNA-FISH            80

8.3.3.1   PNA-FISH tests help hospitals reduce time to pathogen identification     80

TABLE 39              BLOOD CULTURE TESTS MARKET FOR PNA-FISH, BY REGION,

2018-2025 (USD MILLION)            81

8.4          PROTEOMICS     81

8.4.1      MALDI-TOF MS IS ASSOCIATED WITH HIGH ACCURACY   81

TABLE 40              EXAMPLES OF MALDI-TOF MS SYSTEMS                82

TABLE 41              BLOOD CULTURE TESTS MARKET FOR PROTEOMICS, BY REGION,

2018-2025 (USD MILLION)            82

9              BLOOD CULTURE TESTS MARKET, BY APPLICATION           83

9.1          INTRODUCTION                84

TABLE 42              BLOOD CULTURE TESTS MARKET, BY APPLICATION,

2018-2025 (USD MILLION)            84

9.2          BACTEREMIA     84

9.2.1      RISING PREVALENCE OF SEPSIS TO DRIVE THE GROWTH OF THIS SEGMENT           84

TABLE 43              BLOOD CULTURE TESTS MARKET FOR BACTEREMIA, BY REGION,

2018-2025 (USD MILLION)            85

9.3          FUNGEMIA         85

9.3.1      INCREASING INCIDENCE OF BLOODSTREAM INFECTIONS IS SUPPORTING THE GROWTH OF THIS SEGMENT           85

TABLE 44              BLOOD CULTURE TESTS MARKET FOR FUNGEMIA, BY REGION,

2018-2025 (USD MILLION)            85

9.4          MYCOBACTERIAL DETECTION     86

9.4.1      RISING NUMBER OF TB CASES—KEY FACTOR DRIVING MARKET GROWTH             86

TABLE 45              BLOOD CULTURE TESTS MARKET FOR MYCOBACTERIAL DETECTION,

BY REGION, 2018-2025 (USD MILLION)   86

10           BLOOD CULTURE TESTS MARKET, BY END USER  87

10.1        INTRODUCTION                88

TABLE 46              BLOOD CULTURE TESTS MARKET, BY END USER, 2018-2025 (USD MILLION)            88

10.2        HOSPITAL LABORATORIES            88

10.2.1    HOSPITAL LABORATORIES ARE THE LARGEST END USERS OF BLOOD CULTURE TESTS         88

TABLE 47              BLOOD CULTURE TESTS MARKET FOR HOSPITAL LABORATORIES, BY REGION, 2018-2025 (USD MILLION)  89

10.3        REFERENCE LABORATORIES         89

10.3.1    REFERENCE LABORATORIES ARE THE FASTEST-GROWING END USERS OF BLOOD CULTURE TESTS                89

TABLE 48              BLOOD CULTURE TESTS MARKET FOR REFERENCE LABORATORIES,

BY REGION, 2018-2025 (USD MILLION)   90

10.4        ACADEMIC RESEARCH LABORATORIES    90

10.4.1    INCREASING FOCUS ON THE R&D OF INNOVATIVE TESTS FOR BLOODSTREAM INFECTIONS TO DRIVE THE MARKET GROWTH             90

TABLE 49              BLOOD CULTURE TESTS MARKET FOR ACADEMIC RESEARCH LABORATORIES, BY REGION, 2018-2025 (USD MILLION)             90

10.5        OTHER LABORATORIES  91

TABLE 50              BLOOD CULTURE TESTS MARKET FOR OTHER LABORATORIES, BY REGION, 2018-2025 (USD MILLION)        91

11           BLOOD CULTURE TESTS MARKET, BY REGION      92

11.1        INTRODUCTION                93

TABLE 51              BLOOD CULTURE TESTS MARKET, BY REGION, 2018-2025 (USD MILLION)                93

11.2        NORTH AMERICA             94

FIGURE 16           NORTH AMERICA: BLOOD CULTURE TESTS MARKET SNAPSHOT  94

TABLE 52              NORTH AMERICA: BLOOD CULTURE TESTS MARKET, BY COUNTRY,

2018-2025 (USD MILLION)            95

TABLE 53              NORTH AMERICA: BLOOD CULTURE TESTS MARKET, BY METHOD,

2018-2025 (USD MILLION)            95

TABLE 54              NORTH AMERICA: BLOOD CULTURE TESTS MARKET, BY PRODUCT,

2018-2025 (USD MILLION)            95

TABLE 55              NORTH AMERICA: BLOOD CULTURE CONSUMABLES MARKET, BY TYPE,

2018-2025 (USD MILLION)            96

TABLE 56              NORTH AMERICA: BLOOD CULTURE MEDIA MARKET, BY TYPE,

2018-2025 (USD MILLION)            96

TABLE 57              NORTH AMERICA: BLOOD CULTURE INSTRUMENTS MARKET, BY TYPE,

2018-2025 (USD MILLION)            96

TABLE 58              NORTH AMERICA: BLOOD CULTURE TESTS MARKET FOR SUPPORTING LABORATORY EQUIPMENT, BY TYPE, 2018-2025 (USD MILLION)            97

TABLE 59              NORTH AMERICA: BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY,

2018-2025 (USD MILLION)            97

TABLE 60              NORTH AMERICA: BLOOD CULTURE TESTS MARKET FOR MOLECULAR TECHNOLOGIES, BY TYPE, 2018-2025 (USD MILLION) 97

TABLE 61              NORTH AMERICA: BLOOD CULTURE TESTS MARKET, BY APPLICATION,

2018-2025 (USD MILLION)            98

TABLE 62              NORTH AMERICA: BLOOD CULTURE TESTS MARKET, BY END USER,

2018-2025 (USD MILLION)            98

11.2.1    US          98

11.2.1.1                The US is the largest market for blood culture tests         98

TABLE 63              US: BLOOD CULTURE TESTS MARKET, BY METHOD,

2018-2025 (USD MILLION)            99

TABLE 64              US: BLOOD CULTURE TESTS MARKET, BY PRODUCT,

2018-2025 (USD MILLION)            99

TABLE 65              US: BLOOD CULTURE CONSUMABLES MARKET, BY TYPE,

2018-2025 (USD MILLION)            99

TABLE 66              US: BLOOD CULTURE INSTRUMENTS MARKET, BY TYPE,

2018-2025 (USD MILLION)            100

TABLE 67              US: BLOOD CULTURE TESTS MARKET FOR SUPPORTING LABORATORY EQUIPMENT, BY TYPE, 2018-2025 (USD MILLION)             100

TABLE 68              US: BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY,

2018-2025 (USD MILLION)            100

TABLE 69              US: BLOOD CULTURE TESTS MARKET, BY APPLICATION,

2018-2025 (USD MILLION)            100

TABLE 70              US: BLOOD CULTURE TESTS MARKET, BY END USER,

2018-2025 (USD MILLION)            101

11.2.2    CANADA              101

11.2.2.1                Increasing incidence of bloodstream infections to drive market growth  101

TABLE 71              CANADA: BLOOD CULTURE TESTS MARKET, BY METHOD,

2018-2025 (USD MILLION)            101

TABLE 72              CANADA: BLOOD CULTURE TESTS MARKET, BY PRODUCT,

2018-2025 (USD MILLION)            102

TABLE 73              CANADA: BLOOD CULTURE CONSUMABLES MARKET, BY TYPE,

2018-2025 (USD MILLION)            102

TABLE 74              CANADA: BLOOD CULTURE INSTRUMENTS MARKET, BY TYPE,

2018-2025 (USD MILLION)            102

TABLE 75              CANADA: BLOOD CULTURE TESTS MARKET FOR SUPPORTING LABORATORY EQUIPMENT, BY TYPE, 2018-2025 (USD MILLION)       103

TABLE 76              CANADA: BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY,

2018-2025 (USD MILLION)            103

TABLE 77              CANADA: BLOOD CULTURE TESTS MARKET, BY APPLICATION,

2018-2025 (USD MILLION)            103

TABLE 78              CANADA: BLOOD CULTURE TESTS MARKET, BY END USER,

2018-2025 (USD MILLION)            104

 

11.3        EUROPE               104

TABLE 79              EUROPE: BLOOD CULTURE TESTS MARKET, BY COUNTRY,

2018-2025 (USD MILLION)            104

TABLE 80              EUROPE: BLOOD CULTURE TESTS MARKET, BY METHOD,

2018-2025 (USD MILLION)            105

TABLE 81              EUROPE: BLOOD CULTURE TESTS MARKET, BY PRODUCT,

2018-2025 (USD MILLION)            105

TABLE 82              EUROPE: BLOOD CULTURE CONSUMABLES MARKET, BY TYPE,

2018-2025 (USD MILLION)            105

TABLE 83              EUROPE: BLOOD CULTURE MEDIA MARKET, BY TYPE,

2018-2025 (USD MILLION)            105

TABLE 84              EUROPE: BLOOD CULTURE INSTRUMENTS MARKET, BY TYPE,

2018-2025 (USD MILLION)            106

TABLE 85              EUROPE: BLOOD CULTURE TESTS MARKET FOR SUPPORTING LABORATORY EQUIPMENT, BY TYPE, 2018-2025 (USD MILLION) 106

TABLE 86              EUROPE: BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY,

2018-2025 (USD MILLION)            106

TABLE 87              EUROPE: BLOOD CULTURE TESTS MARKET FOR MOLECULAR TECHNOLOGIES, BY TYPE, 2018-2025 (USD MILLION)             107

TABLE 88              EUROPE: BLOOD CULTURE TESTS MARKET, BY APPLICATION,

2018-2025 (USD MILLION)            107

TABLE 89              EUROPE: BLOOD CULTURE TESTS MARKET, BY END USER,

2018-2025 (USD MILLION)            107

11.3.1    GERMANY           108

11.3.1.1                Germany is the largest market for blood culture test products in Europe               108

TABLE 90              GERMANY: BLOOD CULTURE TESTS MARKET, BY METHOD,

2018-2025 (USD MILLION)            108

TABLE 91              GERMANY: BLOOD CULTURE TESTS MARKET, BY PRODUCT,

2018-2025 (USD MILLION)            108

TABLE 92              GERMANY: BLOOD CULTURE CONSUMABLES MARKET, BY TYPE,

2018-2025 (USD MILLION)            108

TABLE 93              GERMANY: BLOOD CULTURE INSTRUMENTS MARKET, BY TYPE,

2018-2025 (USD MILLION)            109

TABLE 94              GERMANY: BLOOD CULTURE TESTS MARKET FOR SUPPORTING LABORATORY EQUIPMENT, BY TYPE, 2018-2025 (USD MILLION)       109

TABLE 95              GERMANY: BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY,

2018-2025 (USD MILLION)            109

TABLE 96              GERMANY: BLOOD CULTURE TESTS MARKET, BY APPLICATION,

2018-2025 (USD MILLION)            110

TABLE 97              GERMANY: BLOOD CULTURE TESTS MARKET, BY END USER,

2018-2025 (USD MILLION)            110

11.3.2    UK          110

11.3.2.1                High burden of sepsis in the UK to drive the adoption of blood culture testing products 110

TABLE 98              UK: BLOOD CULTURE TESTS MARKET, BY METHOD,

2018-2025 (USD MILLION)            111

TABLE 99              UK: BLOOD CULTURE TESTS MARKET, BY PRODUCT,

2018-2025 (USD MILLION)            111

TABLE 100            UK: BLOOD CULTURE CONSUMABLES MARKET, BY TYPE,

2018-2025 (USD MILLION)            111

TABLE 101            UK: BLOOD CULTURE INSTRUMENTS MARKET, BY TYPE,

2018-2025 (USD MILLION)            111

TABLE 102            UK: BLOOD CULTURE TESTS MARKET FOR SUPPORTING LABORATORY EQUIPMENT, BY TYPE, 2018-2025 (USD MILLION) 112

TABLE 103            UK: BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY,

2018-2025 (USD MILLION)            112

TABLE 104            UK: BLOOD CULTURE TESTS MARKET, BY APPLICATION,

2018-2025 (USD MILLION)            112

TABLE 105            UK: BLOOD CULTURE TESTS MARKET, BY END USER,

2018-2025 (USD MILLION)            113

11.3.3    FRANCE                113

11.3.3.1                Rising geriatric population in France to drive the adoption of blood culture testing products         113

TABLE 106            FRANCE: BLOOD CULTURE TESTS MARKET, BY METHOD,

2018-2025 (USD MILLION)            113

TABLE 107            FRANCE: BLOOD CULTURE TESTS MARKET, BY PRODUCT,

2018-2025 (USD MILLION)            114

TABLE 108            FRANCE: BLOOD CULTURE CONSUMABLES MARKET, BY TYPE,

2018-2025 (USD MILLION)            114

TABLE 109            FRANCE: BLOOD CULTURE INSTRUMENTS MARKET, BY TYPE,

2018-2025 (USD MILLION)            114

TABLE 110            FRANCE: BLOOD CULTURE TESTS MARKET FOR SUPPORTING LABORATORY EQUIPMENT, BY TYPE, 2018-2025 (USD MILLION) 115

TABLE 111            FRANCE: BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY,

2018-2025 (USD MILLION)            115

TABLE 112            FRANCE: BLOOD CULTURE TESTS MARKET, BY APPLICATION,

2018-2025 (USD MILLION)            115

TABLE 113            FRANCE: BLOOD CULTURE TESTS MARKET, BY END USER,

2018-2025 (USD MILLION)            116

11.3.4    ITALY     116

11.3.4.1                Sluggish growth in the Italian healthcare sector to hamper the market growth    116

TABLE 114            ITALY: BLOOD CULTURE TESTS MARKET, BY METHOD,

2018-2025 (USD MILLION)            116

TABLE 115            ITALY: BLOOD CULTURE TESTS MARKET, BY PRODUCT,

2018-2025 (USD MILLION)            116

TABLE 116            ITALY: BLOOD CULTURE CONSUMABLES MARKET, BY TYPE,

2018-2025 (USD MILLION)            117

TABLE 117            ITALY: BLOOD CULTURE TESTS MARKET FOR SUPPORTING LABORATORY EQUIPMENT, BY TYPE, 2018-2025 (USD MILLION) 117

TABLE 118            ITALY: BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY,

2018-2025 (USD MILLION)            117

TABLE 119            ITALY: BLOOD CULTURE TESTS MARKET, BY APPLICATION,

2018-2025 (USD MILLION)            118

TABLE 120            ITALY: BLOOD CULTURE TESTS MARKET, BY END USER,

2018-2025 (USD MILLION)            118

 

11.3.5    SPAIN   118

11.3.5.1                Improving healthcare infrastructure to support market growth  118

TABLE 121            SPAIN: BLOOD CULTURE TESTS MARKET, BY METHOD,

2018-2025 (USD MILLION)            119

TABLE 122            SPAIN: BLOOD CULTURE TESTS MARKET, BY PRODUCT,

2018-2025 (USD MILLION)            119

TABLE 123            SPAIN: BLOOD CULTURE CONSUMABLES MARKET, BY TYPE,

2018-2025 (USD MILLION)            119

TABLE 124            SPAIN: BLOOD CULTURE INSTRUMENTS MARKET, BY TYPE,

2018-2025 (USD MILLION)            119

TABLE 125            SPAIN: BLOOD CULTURE TESTS MARKET FOR SUPPORTING LABORATORY EQUIPMENT, BY TYPE, 2018-2025 (USD MILLION) 120

TABLE 126            SPAIN: BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY,

2018-2025 (USD MILLION)            120

TABLE 127            SPAIN: BLOOD CULTURE TESTS MARKET, BY APPLICATION,

2018-2025 (USD MILLION)            120

TABLE 128            SPAIN: BLOOD CULTURE TESTS MARKET, BY END USER,

2018-2025 (USD MILLION)            121

11.3.6    REST OF EUROPE (ROE) 121

TABLE 129            ROE: BLOOD CULTURE TESTS MARKET, BY METHOD,

2018-2025 (USD MILLION)            121

TABLE 130            ROE: BLOOD CULTURE TESTS MARKET, BY PRODUCT,

2018-2025 (USD MILLION)            122

TABLE 131            ROE: BLOOD CULTURE CONSUMABLES MARKET, BY TYPE,

2018-2025 (USD MILLION)            122

TABLE 132            ROE: BLOOD CULTURE INSTRUMENTS MARKET, BY TYPE,

2018-2025 (USD MILLION)            122

TABLE 133            ROE: BLOOD CULTURE TESTS MARKET FOR SUPPORTING LABORATORY EQUIPMENT, BY TYPE, 2018-2025 (USD MILLION) 123

TABLE 134            ROE: BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY,

2018-2025 (USD MILLION)            123

TABLE 135            ROE: BLOOD CULTURE TESTS MARKET, BY APPLICATION,

2018-2025 (USD MILLION)            123

TABLE 136            ROE: BLOOD CULTURE TESTS MARKET, BY END USER,

2018-2025 (USD MILLION)            124

11.4        ASIA PACIFIC     124

TABLE 137            ASIA PACIFIC: BLOOD CULTURE TESTS MARKET, BY COUNTRY,

2018-2025 (USD MILLION)            124

TABLE 138            ASIA PACIFIC: BLOOD CULTURE TESTS MARKET, BY METHOD,

2018-2025 (USD MILLION)            124

TABLE 139            ASIA PACIFIC: BLOOD CULTURE TESTS MARKET, BY PRODUCT,

2018-2025 (USD MILLION)            125

TABLE 140            ASIA PACIFIC: BLOOD CULTURE CONSUMABLES MARKET, BY TYPE,

2018-2025 (USD MILLION)            125

TABLE 141            ASIA PACIFIC: BLOOD CULTURE MEDIA MARKET, BY TYPE,

2018-2025 (USD MILLION)            125

TABLE 142            ASIA PACIFIC: BLOOD CULTURE INSTRUMENTS MARKET, BY TYPE,

2018-2025 (USD MILLION)            126

TABLE 143            ASIA PACIFIC: BLOOD CULTURE TESTS MARKET FOR SUPPORTING LABORATORY EQUIPMENT, BY TYPE, 2018-2025 (USD MILLION)            126

TABLE 144            ASIA PACIFIC: BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY,

2018-2025 (USD MILLION)            126

TABLE 145            ASIA PACIFIC: BLOOD CULTURE TESTS MARKET FOR MOLECULAR TECHNOLOGIES, BY TYPE, 2018-2025 (USD MILLION)             127

TABLE 146            ASIA PACIFIC: BLOOD CULTURE TESTS MARKET, BY APPLICATION,

2018-2025 (USD MILLION)            127

TABLE 147            ASIA PACIFIC: BLOOD CULTURE TESTS MARKET, BY END USER,

2018-2025 (USD MILLION)            127

11.4.1    JAPAN  128

11.4.1.1                Japan is the largest market for blood culture tests in the APAC   128

TABLE 148            JAPAN: BLOOD CULTURE TESTS MARKET, BY METHOD,

2018-2025 (USD MILLION)            128

TABLE 149            JAPAN: BLOOD CULTURE TESTS MARKET, BY PRODUCT,

2018-2025 (USD MILLION)            128

TABLE 150            JAPAN: BLOOD CULTURE CONSUMABLES MARKET, BY TYPE,

2018-2025 (USD MILLION)            129

TABLE 151            JAPAN: BLOOD CULTURE INSTRUMENTS MARKET, BY TYPE,

2018-2025 (USD MILLION)            129

TABLE 152            JAPAN: BLOOD CULTURE TESTS MARKET FOR SUPPORTING LABORATORY EQUIPMENT, BY TYPE, 2018-2025 (USD MILLION) 129

TABLE 153            JAPAN: BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY,

2018-2025 (USD MILLION)            130

TABLE 154            JAPAN: BLOOD CULTURE TESTS MARKET, BY APPLICATION,

2018-2025 (USD MILLION)            130

TABLE 155            JAPAN: BLOOD CULTURE TESTS MARKET, BY END USER,

2018-2025 (USD MILLION)            130

11.4.2    CHINA   131

11.4.2.1                China is the fastest-growing market for blood culture tests          131

TABLE 156            CHINA: BLOOD CULTURE TESTS MARKET, BY METHOD,

2018-2025 (USD MILLION)            131

TABLE 157            CHINA: BLOOD CULTURE TESTS MARKET, BY PRODUCT,

2018-2025 (USD MILLION)            131

TABLE 158            CHINA: BLOOD CULTURE CONSUMABLES MARKET, BY TYPE,

2018-2025 (USD MILLION)            132

TABLE 159            CHINA: BLOOD CULTURE INSTRUMENTS MARKET, BY TYPE,

2018-2025 (USD MILLION)            132

TABLE 160            CHINA: BLOOD CULTURE TESTS MARKET FOR SUPPORTING LABORATORY EQUIPMENT, BY TYPE, 2018-2025 (USD MILLION) 132

TABLE 161            CHINA: BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY,

2018-2025 (USD MILLION)            133

TABLE 162            CHINA: BLOOD CULTURE TESTS MARKET, BY APPLICATION,

2018-2025 (USD MILLION)            133

TABLE 163            CHINA: BLOOD CULTURE TESTS MARKET, BY END USER,

2018-2025 (USD MILLION)            133

11.4.3    INDIA    134

11.4.3.1                Rising prevalence of infectious diseases to propel market growth             134

TABLE 164            INDIA: BLOOD CULTURE TESTS MARKET, BY METHOD,

2018-2025 (USD MILLION)            134

TABLE 165            INDIA: BLOOD CULTURE TESTS MARKET, BY PRODUCT,

2018-2025 (USD MILLION)            134

TABLE 166            INDIA: BLOOD CULTURE CONSUMABLES MARKET, BY TYPE,

2018-2025 (USD MILLION)            135

TABLE 167            INDIA: BLOOD CULTURE INSTRUMENTS MARKET, BY TYPE,

2018-2025 (USD MILLION)            135

TABLE 168            INDIA: BLOOD CULTURE TESTS MARKET FOR SUPPORTING LABORATORY EQUIPMENT, BY TYPE, 2018-2025 (USD MILLION) 135

TABLE 169            INDIA: BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY,

2018-2025 (USD MILLION)            136

TABLE 170            INDIA: BLOOD CULTURE TESTS MARKET, BY APPLICATION,

2018-2025 (USD MILLION)            136

TABLE 171            INDIA: BLOOD CULTURE TESTS MARKET, BY END USER,

2018-2025 (USD MILLION)            136

11.4.4    REST OF ASIA PACIFIC (ROAPAC)              136

TABLE 172            ROAPAC: BLOOD CULTURE TESTS MARKET, BY METHOD,

2018-2025 (USD MILLION)            137

TABLE 173            ROAPAC: BLOOD CULTURE TESTS MARKET, BY PRODUCT,

2018-2025 (USD MILLION)            137

TABLE 174            ROAPAC: BLOOD CULTURE CONSUMABLES MARKET, BY TYPE,

2018-2025 (USD MILLION)            137

TABLE 175            ROAPAC: BLOOD CULTURE INSTRUMENTS MARKET, BY TYPE,

2018-2025 (USD MILLION)            137

TABLE 176            ROAPAC: BLOOD CULTURE TESTS MARKET FOR SUPPORTING LABORATORY EQUIPMENT, BY TYPE, 2018-2025 (USD MILLION)       138

TABLE 177            ROAPAC: BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY,

2018-2025 (USD MILLION)            138

TABLE 178            ROAPAC: BLOOD CULTURE TESTS MARKET, BY APPLICATION,

2018-2025 (USD MILLION)            138

TABLE 179            ROAPAC: BLOOD CULTURE TESTS MARKET, BY END USER,

2018-2025 (USD MILLION)            139

11.5        LATIN AMERICA                139

11.5.1    FAVORABLE GOVERNMENT INITIATIVES TO FAVOR MARKET GROWTH   139

TABLE 180            LATAM: BLOOD CULTURE TESTS MARKET, BY METHOD,

2018-2025 (USD MILLION)            140

TABLE 181            LATAM: BLOOD CULTURE TESTS MARKET, BY PRODUCT,

2018-2025 (USD MILLION)            140

TABLE 182            LATAM: BLOOD CULTURE CONSUMABLES MARKET, BY TYPE,

2018-2025 (USD MILLION)            140

TABLE 183            LATAM: BLOOD CULTURE MEDIA MARKET, BY TYPE,

2018-2025 (USD MILLION)            141

TABLE 184            LATAM: BLOOD CULTURE INSTRUMENTS MARKET, BY TYPE,

2018-2025 (USD MILLION)            141

TABLE 185            LATAM: BLOOD CULTURE TESTS MARKET FOR SUPPORTING LABORATORY EQUIPMENT, BY TYPE, 2018-2025 (USD MILLION) 141

TABLE 186            LATAM: BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY,

2018-2025 (USD MILLION)            142

TABLE 187            LATAM: BLOOD CULTURE TESTS MARKET FOR MOLECULAR TECHNOLOGIES, BY TYPE, 2018-2025 (USD MILLION)             142

TABLE 188            LATAM: BLOOD CULTURE TESTS MARKET, BY APPLICATION,

2018-2025 (USD MILLION)            142

TABLE 189            LATAM: BLOOD CULTURE TESTS MARKET, BY END USER,

2018-2025 (USD MILLION)            143

11.6        MIDDLE EAST & AFRICA 143

11.6.1    INFRASTRUCTURAL DEVELOPMENTS TO SUPPORT MARKET GROWTH IN

THE REGION       143

TABLE 190            MEA: BLOOD CULTURE TESTS MARKET, BY METHOD,

2018-2025 (USD MILLION)            143

TABLE 191            MEA: BLOOD CULTURE TESTS MARKET, BY PRODUCT,

2018-2025 (USD MILLION)            144

TABLE 192            MEA: BLOOD CULTURE CONSUMABLES MARKET, BY TYPE,

2018-2025 (USD MILLION)            144

TABLE 193            MEA: BLOOD CULTURE MEDIA MARKET, BY TYPE, 2018-2025 (USD MILLION)        144

TABLE 194            MEA: BLOOD CULTURE INSTRUMENTS MARKET, BY TYPE,

2018-2025 (USD MILLION)            145

TABLE 195            MEA: BLOOD CULTURE TESTS MARKET FOR SUPPORTING LABORATORY EQUIPMENT, BY TYPE, 2018-2025 (USD MILLION) 145

TABLE 196            MEA: BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY,

2018-2025 (USD MILLION)            145

TABLE 197            MEA: BLOOD CULTURE TESTS MARKET FOR MOLECULAR TECHNOLOGIES,

BY TYPE, 2018-2025 (USD MILLION)          146

TABLE 198            MEA: BLOOD CULTURE TESTS MARKET, BY APPLICATION,

2018-2025 (USD MILLION)            146

TABLE 199            MEA: BLOOD CULTURE TESTS MARKET, BY END USER,

2018-2025 (USD MILLION)            146

12           COMPETITIVE LANDSCAPE           147

12.1        OVERVIEW          147

FIGURE 17           KEY DEVELOPMENTS IN THE BLOOD CULTURE TESTS MARKET      147

FIGURE 18           MARKET EVOLUTION FRAMEWORK         148

12.2        COMPETITIVE SITUATIONS & TRENDS     148

12.2.1    PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS (2017–2020)       148

12.2.2    PRODUCT LAUNCHES & APPROVALS (2017-2020)              149

12.2.3    ACQUISITIONS (2017-2020)         149

13           COMPANY EVALUATION MATRIX AND COMPANY PROFILES        150

13.1        OVERVIEW          150

13.2        COMPANY EVALUATION MATRIX DEFINITION AND METHODOLOGY        150

13.3        MARKET SHARE ANALYSIS            150

13.3.1    INTRODUCTION                150

FIGURE 19           MARKET SHARE ANALYSIS, BY KEY PLAYER, 2019                150

13.4        COMPANY EVALUATION MATRIX             151

13.4.1    STARS   151

13.4.2    EMERGING LEADERS      151

13.4.3    PERVASIVE PLAYERS       152

13.4.4    PARTICIPANTS  152

FIGURE 20           MNM VENDOR DIVE COMPARISON MATRIX: BLOOD CULTURE TESTS MARKET    152

14           COMPANY PROFILES      153

(Business overview, Products offered, Recent developments, MNM view)*

14.1        BECTON, DICKINSON AND COMPANY     153

FIGURE 21           BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2019)        154

14.2        BIOMÉRIEUX SA               157

FIGURE 22           BIOMÉRIEUX SA: COMPANY SNAPSHOT (2019)  157

14.3        THERMO FISHER SCIENTIFIC, INC.             160

FIGURE 23           THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2019)           160

14.4        DANAHER CORPORATION            162

FIGURE 24           DANAHER CORPORATION: COMPANY SNAPSHOT (2019)               162

14.5        LUMINEX CORPORATION             165

FIGURE 25           LUMINEX CORPORATION: COMPANY SNAPSHOT (2019)                165

14.6        BRUKER CORPORATION                167

FIGURE 26           BRUKER CORPORATION: COMPANY SNAPSHOT (2019)   167

14.7        ROCHE DIAGNOSTICS (A DIVISION OF F. HOFFMANN-LA ROCHE LTD.)     169

FIGURE 27           ROCHE DIAGNOSTICS: COMPANY SNAPSHOT (2019)        169

14.8        IRIDICA (A SUBSIDIARY OF ABBOTT LABORATORIES)        171

FIGURE 28           ABBOTT LABORATORIES: COMPANY SNAPSHOT (2019)   171

14.9        T2 BIOSYSTEMS, INC.      172

FIGURE 29           T2 BIOSYSTEMS: COMPANY SNAPSHOT (2019)    172

14.10     BINDER GMBH  173

14.11     BIOBASE BIOTECH (JINAN) CO., LTD.       174

14.12     SCENKER BIOLOGICAL TECHNOLOGY CO., LTD     175

14.13     BULLDOG BIO, INC.         176

14.14     AXIOM LABORATORIES 177

14.15     HIMEDIA LABORATORIES PVT. LTD.          178

14.16     ANAEROBE SYSTEMS, INC.           179

14.17     OPGEN, INC.      179

14.18     MEDITECH TECHNOLOGIES INDIA PRIVATE LIMITED         180

14.19     CARL ZEISS AG   180

14.20     NIKON CORPORATION  181

*Business overview, Products offered, Recent developments, MNM view might not be captured in case of unlisted companies.

 

15           APPENDIX           182

15.1        DISCUSSION GUIDE        182

15.2        KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL   187

15.3        AVAILABLE CUSTOMIZATIONS   189

15.4        RELATED REPORTS           189

15.5        AUTHOR DETAILS             190

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Lateral Flow Assay Components Market by Type, Application Type (Clinical Testing (Infectious, Cardiac Marker Test) Veterinary, Food Safety), Technique...

Publisher:        MarketsandMarkets

# of Pages:        224

Rating: 

1 User License $4,950

Publication Date:  April, 2022

Price:       $4,950 / User License




1 INTRODUCTION 33
1.1 OBJECTIVES OF THE STUDY 33
1.2 MARKET DEFINITION 33
1.2.1 CATEGORY-WISE INCLUSIONS AND EXCLUSIONS
IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 33
1.3 MARKET SCOPE 34
1.3.1 MARKETS COVERED 34
FIGURE 1 LATERAL FLOW ASSAY COMPONENTS MARKET SEGMENTATION 34
1.3.2 YEARS CONSIDERED FOR THE STUDY 35
1.4 CURRENCY 35
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 35
1.5 STAKEHOLDERS 35
2 RESEARCH METHODOLOGY 36
2.1 RESEARCH APPROACH 36
FIGURE 2 RESEARCH DESIGN 36
2.1.1 SECONDARY DATA 36
2.1.1.1 Key data from secondary sources 37
2.1.2 PRIMARY DATA 38
2.1.2.1 Primary sources 38
2.1.2.2 Key data from primary sources 39
2.1.2.3 Breakdown of primaries 39
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE):
BY COMPANY TYPE, DESIGNATION, AND REGION 39
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION 40
2.2 MARKET SIZE ESTIMATION 40
FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2021) 41
FIGURE 6 SUPPLY-SIDE ANALYSIS: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 42
2.3 MARKET BREAKDOWN & DATA TRIANGULATION 44
FIGURE 7 DATA TRIANGULATION METHODOLOGY 45
2.4 KEY INDUSTRY INSIGHTS 46
2.5 LIMITATIONS 46
2.5.1 METHODOLOGY-RELATED LIMITATIONS 46
2.6 RISK ASSESSMENT 47
2.7 ASSUMPTIONS FOR THE STUDY 47
 
3 EXECUTIVE SUMMARY 48
FIGURE 8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2022 VS. 2027 (USD MILLION) 48
FIGURE 9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2022 VS. 2027 (USD MILLION) 49
FIGURE 10 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2022 VS. 2027 (USD MILLION) 50
FIGURE 11 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2022 VS. 2027 (USD MILLION) 51
FIGURE 12 GEOGRAPHICAL SNAPSHOT OF THE LATERAL FLOW ASSAY COMPONENTS MARKET 52
4 PREMIUM INSIGHTS 53
4.1 LATERAL FLOW ASSAY COMPONENTS MARKET OVERVIEW 53
FIGURE 13 RISING NUMBER OF LOCAL MANUFACTURERS FOR COMPONENTS IS DRIVING THE GROWTH OF THE LATERAL FLOW ASSAY COMPONENTS MARKET 53
4.2 REGIONAL MIX: LATERAL FLOW ASSAY COMPONENTS MARKET 54
FIGURE 14 APAC TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD 54
4.3 ASIA PACIFIC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE AND COUNTRY 55
FIGURE 15 MEMBRANES ACCOUNTED FOR THE LARGEST SHARE OF THE ASIA PACIFIC MARKET IN 2021 55
4.4 LATERAL FLOW ASSAY COMPONENTS MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES 56
4.5 LATERAL FLOW ASSAY COMPONENTS MARKET: DEVELOPED VS. DEVELOPING COUNTRIES 56
5 MARKET OVERVIEW 57
5.1 INTRODUCTION 57
5.2 MARKET DYNAMICS: IMPACT ANALYSIS 57
5.2.1 DRIVERS 58
5.2.1.1 Growing demand for lateral flow assay kits due
to the COVID-19 pandemic 58
5.2.1.2 Growing usage of home-based lateral flow assay devices 58
5.2.1.3 Growing demand for point-of-care testing 58
5.2.1.4 Increasing public-private investments to develop lateral flow assays 59
5.2.2 RESTRAINTS 59
5.2.2.1 Availability of alternative diagnostic technologies 59
5.2.3 OPPORTUNITIES 59
5.2.3.1 Evolving applications of lateral flow assays 59
5.2.4 CHALLENGES 60
5.2.4.1 Requirement of specialized storage and shipping facilities for membranes 60
5.3 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 60
5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES (YC-YCC) IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 60
FIGURE 16 YC–YCC SHIFT IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 61
5.5 AVERAGE SELLING PRICE TREND 61
TABLE 2 AVERAGE SELLING PRICE OF LATERAL FLOW ASSAY COMPONENTS,
BY REGION, 2021 (USD) 61
5.6 ECOSYSTEM MARKET MAP 62
FIGURE 17 ECOSYSTEM: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 62
5.7 PATENT ANALYSIS 63
5.7.1 PATENT PUBLICATION TRENDS FOR LATERAL FLOW ASSAYS 63
FIGURE 18 GLOBAL PATENT PUBLICATION TRENDS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET, 2016–2021 64
5.7.2 JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR PATENTS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 64
FIGURE 19 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR LATERAL FLOW ASSAYS COMPONENTS, 2016–2021 64
5.8 VALUE CHAIN ANALYSIS 65
5.9 REGULATORY LANDSCAPE 66
TABLE 3 REGULATORY STANDARDS/APPROVALS REQUIRED FOR LATERAL FLOW IMMUNOASSAY PRODUCTS, BY COUNTRY/REGION 66
5.9.1 NORTH AMERICA 66
5.9.2 EUROPE 67
5.9.3 ASIA PACIFIC 67
5.9.3.1 India 67
5.9.3.2 China 67
5.9.3.3 Japan 68
5.10 TECHNOLOGY ANALYSIS 69
5.10.1 KEY TECHNOLOGY: LATERAL FLOW ASSAYS 69
5.11 KEY CONFERENCES & EVENTS DURING 2021–2023 69
TABLE 4 LATERAL FLOW ASSAY COMPONENTS MARKET: DETAILED LIST OF CONFERENCES & EVENTS 69
5.12 KEY STAKEHOLDERS & BUYING CRITERIA 70
5.12.1 KEY STAKEHOLDERS IN THE BUYING PROCESS 70
FIGURE 20 INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS FOR THE TOP 3 APPLICATIONS 70
TABLE 5 INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS FOR THE TOP 3 APPLICATIONS 70
5.12.2 BUYING CRITERIA 71
FIGURE 21 KEY BUYING CRITERIA FOR THE TOP 3 APPLICATIONS 71
TABLE 6 KEY BUYING CRITERIA FOR THE TOP 3 APPLICATIONS 71
5.13 PORTER’S FIVE FORCES ANALYSIS 72
TABLE 7 LATERAL FLOW ASSAY COMPONENTS MARKET:
PORTER’S FIVE FORCES ANALYSIS 72
5.13.1 THREAT FROM NEW ENTRANTS 72
5.13.2 THREAT FROM SUBSTITUTES 72
5.13.3 BARGAINING POWER OF BUYERS 73
5.13.4 BARGAINING POWER OF SUPPLIERS 73
5.13.5 INTENSITY OF COMPETITIVE RIVALRY 73
6 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE 74
6.1 INTRODUCTION 75
TABLE 8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 75
6.2 MEMBRANES 75
TABLE 9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE,
2020–2027 (USD MILLION) 76
TABLE 10 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEMBRANES,
BY COUNTRY, 2020–2027 (USD MILLION) 76
6.2.1 NITROCELLULOSE MEMBRANES 77
6.2.1.1 Advantages of nitrocellulose membranes such as high protein-binding affinity and compatibility with a wide range of detection methods to drive market growth 77
TABLE 11 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES, BY COUNTRY, 2020–2027 (USD MILLION) 77
TABLE 12 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES (1 X 1 M SHEETS), BY REGION, 2020–2027 (IN THOUSANDS) 78
TABLE 13 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES (20 MM X 1 M ROLLS), BY REGION, 2020–2027 (IN MILLIONS) 78
6.2.2 OTHER MEMBRANES 78
TABLE 14 LATERAL FLOW ASSAY COMPONENTS MARKET FOR OTHER MEMBRANES,
BY COUNTRY, 2020–2027 (USD MILLION) 79
6.3 PADS 80
TABLE 15 EXAMPLES OF DIFFERENT MATERIALS USED IN MANUFACTURING LATERAL FLOW ASSAY PADS 80
TABLE 16 LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 80
TABLE 17 LATERAL FLOW ASSAY COMPONENTS MARKET FOR PADS, BY COUNTRY, 2020–2027 (USD MILLION) 81
6.3.1 SAMPLE PADS 81
6.3.1.1 Ability to promote even and controlled distribution of samples to drive market growth 81
TABLE 18 LATERAL FLOW ASSAY COMPONENTS MARKET FOR SAMPLE PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 82
6.3.2 CONJUGATE PADS 82
6.3.2.1 Conjugate pads play an important role in controlling the performance of lateral flow immunoassays 82
TABLE 19 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CONJUGATE PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 83
6.3.3 ABSORBENT PADS 84
6.3.3.1 Absorbent pads prevent backflow—a key factor driving market growth 84
TABLE 20 LATERAL FLOW ASSAY COMPONENTS MARKET FOR ABSORBENT PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 84
6.4 OTHER COMPONENTS 84
TABLE 21 OTHER LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 85
7 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION 86
7.1 INTRODUCTION 87
TABLE 22 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 87
7.2 CLINICAL TESTING 87
TABLE 23 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 88
TABLE 24 LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS,
BY COUNTRY, 2020–2027 (USD MILLION) 88
7.2.1 INFECTIOUS DISEASE TESTING 89
7.2.1.1 Rising demand for infectious disease testing in emerging markets to drive market growth 89
TABLE 25 LATERAL FLOW ASSAY COMPONENTS MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 89
7.2.2 PREGNANCY & FERTILITY TESTING 90
7.2.2.1 Growing infertility levels due to changing lifestyles—a key factor driving market growth 90
TABLE 26 LATERAL FLOW ASSAY COMPONENTS MARKET FOR PREGNANCY & FERTILITY TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 90
7.2.3 CARDIAC MARKER TESTING 91
7.2.3.1 Rising prevalence of cardiovascular diseases and growing government support to drive growth in this market segment 91
TABLE 27 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CARDIAC MARKER TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 92
7.2.4 CHOLESTEROL TESTING/LIPID PROFILING 92
7.2.4.1 Growing prevalence of obesity and CVD—
a key factor driving market growth 92
TABLE 28 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CHOLESTEROL TESTING/LIPID PROFILING, BY COUNTRY, 2020–2027 (USD MILLION) 93
7.2.5 DRUGS-OF-ABUSE TESTING 93
7.2.5.1 Technological advancements and a growing focus on workplace
drug testing are driving market growth 93
TABLE 29 LATERAL FLOW ASSAY COMPONENTS MARKET FOR DRUGS-OF-ABUSE TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 94
7.2.6 OTHER CLINICAL TESTING APPLICATIONS 94
TABLE 30 LATERAL FLOW ASSAY COMPONENTS MARKET FOR OTHER CLINICAL TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 95
7.3 VETERINARY DIAGNOSTICS 95
7.3.1 INFECTIOUS DISEASE OUTBREAKS (PARTICULARLY IN LARGE LIVESTOCK ANIMALS) TO DRIVE MARKET GROWTH 95
TABLE 31 LATERAL FLOW ASSAY COMPONENTS MARKET FOR VETERINARY DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 96
7.4 FOOD SAFETY & ENVIRONMENTAL TESTING 96
7.4.1 HIGH SENSITIVITY AND EASE OF USE ARE KEY FACTORS DRIVING THE DEMAND FOR LATERAL FLOW ASSAYS FOR FOOD SAFETY TESTING 96
TABLE 32 LATERAL FLOW ASSAY COMPONENTS MARKET FOR FOOD SAFETY & ENVIRONMENTAL TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 97
7.5 DRUG DEVELOPMENT & QUALITY TESTING 97
7.5.1 INCREASING FOCUS ON PRODUCT SAFETY AND QUALITY ASSURANCE TO DRIVE MARKET GROWTH IN THE COMING YEARS 97
TABLE 33 LATERAL FLOW ASSAY COMPONENTS MARKET FOR DRUG DEVELOPMENT & QUALITY TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 98
8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE 99
8.1 INTRODUCTION 100
TABLE 34 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 100
8.2 SANDWICH ASSAYS 100
8.2.1 SANDWICH ASSAYS PROVIDE HIGHER LEVELS OF ASSAY SENSITIVITY AND SPECIFICITY THAN OTHER ASSAY TECHNIQUES—A KEY FACTOR DRIVING GROWTH IN THIS MARKET SEGMENT 100
TABLE 35 LATERAL FLOW ASSAY COMPONENTS MARKET FOR SANDWICH ASSAYS,
BY COUNTRY, 2020–2027 (USD MILLION) 101
8.3 COMPETITIVE ASSAYS 101
8.3.1 REDUCED SELECTIVITY AND SENSITIVITY OF COMPETITIVE ASSAYS IN RELATION TO SANDWICH ASSAYS COULD HAMPER MARKET GROWTH 101
TABLE 36 LATERAL FLOW ASSAY COMPONENTS MARKET FOR COMPETITIVE ASSAYS,
BY COUNTRY, 2020–2027 (USD MILLION) 102
8.4 MULTIPLEX DETECTION ASSAYS 102
8.4.1 INCREASING ADOPTION OF MULTI-ANALYTE ASSAYS AMONG CLINICIANS TO DRIVE MARKET GROWTH 102
TABLE 37 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MULTIPLEX DETECTION ASSAYS, BY COUNTRY, 2020–2027 (USD MILLION) 103
9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER 104
9.1 INTRODUCTION 105
TABLE 38 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 105
9.2 MEDICAL DEVICE MANUFACTURING COMPANIES 105
9.2.1 INCREASING USE OF POC TESTS IS DRIVING THE ADOPTION OF LATERAL FLOW ASSAY COMPONENTS AMONG MEDICAL DEVICE MANUFACTURING COMPANIES 105
TABLE 39 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEDICAL DEVICE MANUFACTURING COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION) 106
9.3 MEDICAL DEVICE CONTRACT MANUFACTURING COMPANIES 106
9.3.1 GROWING INCLINATION TOWARD FAST AND EARLY DIAGNOSIS, ESPECIALLY IN RELATION TO THE CURRENT COVID-19 SCENARIO, WILL DRIVE MARKET GROWTH 106
TABLE 40 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEDICAL DEVICE CONTRACT MANUFACTURING COMPANIES, BY COUNTRY,
2020–2027 (USD MILLION) 107
 
10 LATERAL FLOW ASSAY COMPONENTS MARKET, BY REGION 108
10.1 INTRODUCTION 109
FIGURE 22 CHINA TO REGISTER THE HIGHEST GROWTH IN THE LATERAL FLOW ASSAY COMPONENTS MARKET DURING THE FORECAST PERIOD 109
TABLE 41 LATERAL FLOW ASSAY COMPONENTS MARKET, BY REGION,
2020–2027 (USD MILLION) 110
10.2 NORTH AMERICA 110
TABLE 42 NORTH AMERICA: MACROECONOMIC INDICATORS 110
FIGURE 23 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET SNAPSHOT 111
TABLE 43 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY COUNTRY, 2020–2027 (USD MILLION) 112
TABLE 44 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 112
TABLE 45 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 112
TABLE 46 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY PAD TYPE, 2020–2027 (USD MILLION) 113
TABLE 47 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 113
TABLE 48 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 114
TABLE 49 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 114
TABLE 50 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 115
10.2.1 US 115
10.2.1.1 Increasing R&D investments and venture capital funding from both large and small firms towards the development of lateral flow assay diagnostics to drive market growth in the US 115
TABLE 51 US: MACROECONOMIC INDICATORS 116
TABLE 52 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 116
TABLE 53 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 116
TABLE 54 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 117
TABLE 55 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 117
TABLE 56 US: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 118
TABLE 57 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 118
TABLE 58 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 119
10.2.2 CANADA 119
10.2.2.1 Lateral flow assay components market in Canada is estimated to grow at a relatively lower rate than the US 119
TABLE 59 CANADA: MACROECONOMIC INDICATORS 119
TABLE 60 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 120
TABLE 61 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 120
TABLE 62 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 120
TABLE 63 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 121
TABLE 64 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 121
TABLE 65 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 122
TABLE 66 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 122
10.3 EUROPE 122
TABLE 67 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 123
TABLE 68 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 123
TABLE 69 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 123
TABLE 70 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 124
TABLE 71 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 124
TABLE 72 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 125
TABLE 73 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 125
TABLE 74 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 126
10.3.1 GERMANY 126
10.3.1.1 Growing demand for POC testing to drive the lateral flow assay components market in Germany 126
TABLE 75 GERMANY: MACROECONOMIC INDICATORS 126
TABLE 76 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 127
TABLE 77 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 127
TABLE 78 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 127
TABLE 79 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 128
TABLE 80 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 128
TABLE 81 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 129
TABLE 82 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 129
10.3.2 FRANCE 129
10.3.2.1 High prevalence of age-related chronic diseases and infectious diseases to drive market growth in France 129
TABLE 83 FRANCE: MACROECONOMIC INDICATORS 130
TABLE 84 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 130
TABLE 85 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 130
TABLE 86 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 131
TABLE 87 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 131
TABLE 88 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 132
TABLE 89 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 132
TABLE 90 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 133
10.3.3 UK 133
10.3.3.1 Severe impact of the second wave of COVID-19 in the first half of 2021 resulted in higher adoption of rapid COVID tests in the UK 133
TABLE 91 UK: MACROECONOMIC INDICATORS 134
TABLE 92 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 134
TABLE 93 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 134
TABLE 94 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 135
TABLE 95 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 135
TABLE 96 UK: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 136
TABLE 97 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 136
TABLE 98 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 137
10.3.4 ITALY 137
10.3.4.1 Growing initiatives towards decentralization of medical services in Italy are contributing to the market growth in the country 137
TABLE 99 ITALY: MACROECONOMIC INDICATORS 137
TABLE 100 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 138
TABLE 101 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 138
TABLE 102 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 138
TABLE 103 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 139
TABLE 104 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 139
TABLE 105 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 140
TABLE 106 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 140
10.3.5 SPAIN 140
10.3.5.1 Increasing focus of international organizations and domestic players on the development of POC products in the country to drive market growth 140
TABLE 107 SPAIN: MACROECONOMIC INDICATORS 141
TABLE 108 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 141
TABLE 109 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 142
TABLE 110 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 142
TABLE 111 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 142
TABLE 112 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 143
TABLE 113 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 143
TABLE 114 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 144
10.3.6 REST OF EUROPE 144
TABLE 115 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 144
TABLE 116 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 145
TABLE 117 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 145
TABLE 118 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 145
TABLE 119 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 146
TABLE 120 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 146
TABLE 121 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 147
10.4 ASIA PACIFIC 147
FIGURE 24 ASIA PACIFIC: LATERAL FLOW ASSAY COMPONENTS MARKET SNAPSHOT 148
TABLE 122 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 149
TABLE 123 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 149
TABLE 124 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 149
TABLE 125 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 150
TABLE 126 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 150
TABLE 127 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 151
TABLE 128 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 151
TABLE 129 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 152
10.4.1 CHINA 152
10.4.1.1 Higher exports of lateral flow assay components during the COVID-19 pandemic to drive market growth in the country 152
TABLE 130 CHINA: MACROECONOMIC INDICATORS 153
TABLE 131 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 153
TABLE 132 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 153
TABLE 133 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 154
TABLE 134 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 154
TABLE 135 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 155
TABLE 136 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 155
TABLE 137 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 156
10.4.2 JAPAN 156
10.4.2.1 Increasing prevalence of age-related illnesses driving the growth of the lateral flow assay components market in Japan 156
TABLE 138 JAPAN: MACROECONOMIC INDICATORS 157
TABLE 139 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 157
TABLE 140 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 157
TABLE 141 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 158
TABLE 142 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 158
TABLE 143 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 159
TABLE 144 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 159
TABLE 145 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 160
10.4.3 INDIA 160
10.4.3.1 Increasing number of local manufacturers, growing healthcare concerns, and rising income levels to propel the growth of this market 160
TABLE 146 INDIA: MACROECONOMIC INDICATORS 160
TABLE 147 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 161
TABLE 148 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 161
TABLE 149 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 161
TABLE 150 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 162
TABLE 151 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 162
TABLE 152 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 163
TABLE 153 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 163
10.4.4 AUSTRALIA 164
10.4.4.1 Increasing prevalence of infectious diseases, especially influenza, to drive the growth of the lateral flow assay components market in Australia 164
TABLE 154 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 164
TABLE 155 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 164
TABLE 156 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 165
TABLE 157 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 165
TABLE 158 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 166
TABLE 159 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 166
TABLE 160 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 167
10.4.5 REST OF ASIA PACIFIC 167
TABLE 161 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 167
TABLE 162 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 168
TABLE 163 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 168
TABLE 164 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 168
TABLE 165 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 169
TABLE 166 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 169
TABLE 167 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 170
 
10.5 LATIN AMERICA 170
10.5.1 HIGH DEMAND FOR HIV POC DEVICES IN THE REGION TO SUPPORT THE GROWTH OF THE MARKET 170
TABLE 168 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 171
TABLE 169 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 171
TABLE 170 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD
TYPE, 2020–2027 (USD MILLION) 171
TABLE 171 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 172
TABLE 172 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 172
TABLE 173 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 173
TABLE 174 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 173
10.6 MIDDLE EAST & AFRICA 173
10.6.1 SIGNIFICANT SUPPORT FROM GOVERNMENTS AND GLOBAL FIRMS TOWARDS EXPANDING HEALTHCARE SERVICES DRIVES THE ADOPTION OF LATERAL FLOW ASSAYS 173
TABLE 175 MIDDLE EAST & AFRICA: MACROECONOMIC INDICATORS 174
TABLE 176 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TYPE, 2020–2027 (USD MILLION) 174
TABLE 177 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 175
TABLE 178 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY PAD TYPE, 2020–2027 (USD MILLION) 175
TABLE 179 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 175
TABLE 180 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 176
TABLE 181 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 176
TABLE 182 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 177
11 COMPETITIVE LANDSCAPE 178
11.1 OVERVIEW 178
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 178
FIGURE 25 OVERVIEW OF STRATEGIES ADOPTED BY MAJOR PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 179
11.3 REVENUE SHARE ANALYSIS FOR KEY PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 179
FIGURE 26 REVENUE SHARE ANALYSIS FOR THE KEY PLAYERS
IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 180
11.4 MARKET SHARE ANALYSIS 180
FIGURE 27 LATERAL FLOW ASSAY COMPONENTS MARKET SHARE ANALYSIS, BY KEY PLAYER (2021) 181
TABLE 183 LATERAL FLOW ASSAY COMPONENTS MARKET: DEGREE OF COMPETITION 182
11.5 R&D ASSESSMENT OF KEY PLAYERS 183
FIGURE 28 R&D EXPENDITURE: MAJOR PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET, 2018 VS. 2020 183
11.6 GEOGRAPHIC REVENUE ASSESSMENT OF KEY PLAYERS 183
FIGURE 29 GEOGRAPHIC REVENUE ASSESSMENT: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 184
11.7 COMPANY EVALUATION QUADRANT 184
11.7.1 STARS 184
11.7.2 PERVASIVE PLAYERS 184
11.7.3 EMERGING LEADERS 185
11.7.4 PARTICIPANTS 185
FIGURE 30 LATERAL FLOW ASSAY COMPONENTS MARKET: COMPANY EVALUATION MATRIX, 2021 185
11.8 COMPETITIVE BENCHMARKING 186
11.8.1 OVERALL COMPANY FOOTPRINT 186
TABLE 184 OVERALL COMPANY FOOTPRINT (17 COMPANIES) 186
TABLE 185 COMPANY FOOTPRINT: BY TYPE (17 COMPANIES) 187
TABLE 186 COMPANY FOOTPRINT: BY REGION (17 COMPANIES) 188
11.9 COMPETITIVE SCENARIO 188
11.9.1 DEALS 189
TABLE 187 DEALS, JANUARY 2019–FEBRUARY 2022 189
11.9.2 OTHER DEVELOPMENTS 189
TABLE 188 OTHER DEVELOPMENTS, JANUARY 2019–FEBRUARY 2022 189
12 COMPANY PROFILES 190
12.1 KEY PLAYERS 190
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1.1 DANAHER CORPORATION (PALL CORPORATION AND CYTIVA LIFE SCIENCE) 190
TABLE 189 DANAHER CORPORATION: BUSINESS OVERVIEW 190
FIGURE 31 DANAHER CORPORATION: COMPANY SNAPSHOT (2020) 191
12.1.2 SARTORIUS STEDIM BIOTECH 195
TABLE 190 SARTORIUS STEDIM BIOTECH: BUSINESS OVERVIEW 195
12.1.3 MERCK KGAA 199
TABLE 191 MERCK KGAA: BUSINESS OVERVIEW 199
FIGURE 33 MERCK KGAA: COMPANY SNAPSHOT (2020) 200
12.1.4 AHLSTROM-MUNKSJÖ 204
TABLE 192 AHLSTROM-MUNKSJÖ: BUSINESS OVERVIEW 204
FIGURE 34 AHLSTROM-MUNKSJÖ: COMPANY SNAPSHOT (2020) 205
12.1.5 ADVANCED MICRODEVICES PVT. LTD. 208
TABLE 193 ADVANCED MICRODEVICES PVT. LTD.: BUSINESS OVERVIEW 208
12.1.6 DCN DIAGNOSTICS 210
TABLE 194 DCN DIAGNOSTICS: BUSINESS OVERVIEW 210
12.2 OTHER PLAYERS 211
12.2.1 FORTIS LIFE SCIENCES 211
TABLE 195 FORTIS LIFE SCIENCES: BUSINESS OVERVIEW 211
12.2.2 HANGZHOU COBETTER FILTRATION EQUIPMENT CO. LTD 212
TABLE 196 HANGZHOU COBETTER FILTRATION EQUIPMENT CO. LTD.:
BUSINESS OVERVIEW 212
12.2.3 AXIVA SICHEM BIOTECH 214
TABLE 197 AXIVA SICHEM BIOTECH: BUSINESS OVERVIEW 214
12.2.4 NUPORE FILTRATION SYSTEM 216
TABLE 198 NUPORE FILTRATION SYSTEM: BUSINESS OVERVIEW 216
12.2.5 BALLYA BIO 217
TABLE 199 BALLYA BIO: BUSINESS OVERVIEW 217
12.2.6 RUNBIO BIOTECH CO. LTD. 219
TABLE 200 RUNBIO BIOTECH CO. LTD.: BUSINESS OVERVIEW 219
12.2.7 NEENAH GESSNER 220
TABLE 201 NEENAH GESSNER: BUSINESS OVERVIEW 220
12.2.8 MAXIM BIOMEDICAL 221
TABLE 202 MAXIM BIOMEDICAL: BUSINESS OVERVIEW 221
12.2.9 CYTODIAGNOSTICS 222
TABLE 203 CYTODIAGNOSTICS: BUSINESS OVERVIEW 222
12.2.10 SENOVA GMBH 223
TABLE 204 SENOVA GMBH: BUSINESS OVERVIEW 223
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
13 APPENDIX 224
13.1 DISCUSSION GUIDE 224
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 229
13.3 AVAILABLE CUSTOMIZATIONS 231
13.4 RELATED REPORTS 231
13.5 AUTHOR DETAILS 232

US Healthcare Environmental Services Market by Type (Janitorial/Core-Cleaning, Infection Control & Prevention, Front-of-house cleaning & Brand Experie...

Publisher:        MarketsandMarkets

# of Pages:        126

Rating: 

1 User License $4,950

Publication Date:  March, 2022

Price:       $4,950 / User License




1 INTRODUCTION 15
1.1 OBJECTIVES OF THE STUDY 15
1.2 MARKET DEFINITION & SCOPE 15
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY 16
1.2.2 MARKET SEGMENTATION 16
FIGURE 1 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET SEGMENTATION 16
1.2.3 YEARS CONSIDERED FOR THE STUDY 17
1.3 CURRENCY 17
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 17
1.4 STAKEHOLDERS 18
2 RESEARCH METHODOLOGY 19
2.1 RESEARCH APPROACH 19
FIGURE 2 RESEARCH DESIGN 19
2.1.1 SECONDARY RESEARCH 20
2.1.1.1 Key data from secondary sources 21
2.1.2 PRIMARY RESEARCH 21
FIGURE 3 PRIMARY SOURCES 22
2.1.2.1 Key data from primary sources 23
2.1.2.2 Insights from primary experts 23
2.1.2.3 Breakdown of primary interviews 24
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE (SUPPLY & DEMAND SIDE) AND DESIGNATION 24
2.2 MARKET SIZE ESTIMATION 25
FIGURE 5 MARKET SIZE APPROACH – REVENUE SHARE ANALYSIS 25
FIGURE 6 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 26
FIGURE 7 DEMAND-SIDE APPROACH 28
2.3 DATA TRIANGULATION 29
FIGURE 8 DATA TRIANGULATION METHODOLOGY 29
2.4 MARKET RANKING ANALYSIS 30
2.5 ASSUMPTIONS FOR THE STUDY 30
2.6 LIMITATIONS 31
2.6.1 METHODOLOGY-RELATED LIMITATIONS 31
2.6.2 SCOPE-RELATED LIMITATIONS 31
2.7 RISK ASSESSMENT 31
TABLE 2 RISK ASSESSMENT: US HEALTHCARE ENVIRONMENTAL SERVICES MARKET 31
 
3 EXECUTIVE SUMMARY 32
FIGURE 9 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE,
2021 VS. 2026 (USD MILLION) 32
FIGURE 10 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET,
BY FACILITY TYPE, 2021 VS. 2026 (USD MILLION) 33
4 PREMIUM INSIGHTS 34
4.1 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET OVERVIEW 34
FIGURE 11 STRINGENT REGULATORY GUIDELINES ON INFECTION CONTROL & PREVENTION METHODS IS A KEY FACTOR DRIVING THE MARKET GROWTH 34
4.2 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE AND FACILITY TYPE 35
FIGURE 12 JANITORIAL/CORE-CLEANING SERVICES ACCOUNTED FOR THE LARGEST SHARE OF THE US HEALTHCARE ENVIRONMENTAL SERVICES
MARKET IN 2020 35
4.3 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE (2021–2026) 36
FIGURE 13 ACUTE CARE FACILITIES TO DOMINATE THE US HEALTHCARE ENVIRONMENTAL SERVICES MARKET DURING THE FORECAST PERIOD 36
5 MARKET OVERVIEW 37
5.1 INTRODUCTION 37
5.2 MARKET DYNAMICS 37
TABLE 3 MARKET DYNAMICS: HEALTHCARE ENVIRONMENTAL SERVICES MARKET 37
5.2.1 MARKET DRIVERS 38
5.2.1.1 Increasing prevalence of Hospital-acquired infections (HAIs) 38
5.2.1.2 Rising number of hospital admissions and surgeries 39
TABLE 4 US: PERCENTAGE INCREASE IN THE NUMBER OF SURGERIES PERFORMED 39
FIGURE 14 TOTAL ADMISSIONS IN ALL US HOSPITALS 40
FIGURE 15 TOTAL NUMBER OF HOSPITALS IN THE US 40
5.2.1.3 Shortage of in-house expertise and the rising need to reduce healthcare costs 41
5.2.1.4 Increasing outsourcing of cleaning services 41
5.2.2 MARKET RESTRAINTS 41
5.2.2.1 Healthcare facilities with an in-house EVS department 41
5.2.3 MARKET OPPORTUNITIES 42
5.2.3.1 Sustained acquisitions among strategic & financial buyers 42
TABLE 5 COMPANY ACQUISITIONS 42
5.2.4 MARKET CHALLENGES 42
5.2.4.1 Noncompliance with cleaning standards by EVS providers 42
5.3 INDUSTRY TRENDS 43
5.3.1 EMERGENCE OF NEW SURFACE DISINFECTANTS &
GREEN CLEANING PRODUCTS 43
5.3.2 DISINFECTION ROBOTS 44
5.3.3 MONITORING TOOLS FOR CLEANING QUALITY ASSESSMENT 44
5.4 TECHNOLOGY ANALYSIS 45
TABLE 6 TECHNOLOGY INNOVATION IN THE HEALTHCARE ENVIRONMENTAL
SERVICES MARKET 45
5.5 PATENT ANALYSIS 45
5.5.1 PATENT PUBLICATION TRENDS FOR HEALTHCARE ENVIRONMENTAL SERVICES 46
FIGURE 16 PATENT PUBLICATION TRENDS (JANUARY 2011–DECEMBER 2021) 46
5.5.2 JURISDICTION AND TOP APPLICANT ANALYSIS 47
FIGURE 17 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR HEALTHCARE ENVIRONMENTAL SERVICES PATENTS (JANUARY 2011–JANUARY 2022) 47
FIGURE 18 TOP APPLICANT COUNTRIES/REGIONS FOR HEALTHCARE ENVIRONMENTAL SERVICES PATENTS (JANUARY 2011–JANUARY 2022) 48
TABLE 7 LIST OF PATENTS/PATENT APPLICATIONS IN THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET, 2020–2021 48
5.6 IMPACT OF COVID-19 ON THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET 50
6 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE 51
6.1 INTRODUCTION 52
TABLE 8 US: HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 52
6.2 JANITORIAL SERVICES/CORE-CLEANING SERVICES 52
6.2.1 MANDATORY REGULAR CLEANING AND DISINFECTION OF HEALTHCARE FACILITIES TO DRIVE THE MARKET GROWTH 52
6.3 INFECTION PREVENTION & CONTROL SERVICES 53
TABLE 9 US: INFECTION PREVENTION & CONTROL SERVICE MARKET, BY TYPE,
2019–2026 (USD MILLION) 53
6.3.1 SPECIALIZED CLEANING SERVICES 53
6.3.1.1 Rising adoption of specialized services to reduce HAIs to drive the market growth 53
6.3.2 INFECTION PREVENTION & CONTROL CONSULTATION SERVICES 53
6.3.2.1 The provision of customized environmental services specific
to a healthcare facility ensures market demand 53
6.4 ENHANCED CLEANING TECHNOLOGY 54
6.4.1 RISING DEMAND FOR ADVANCED CLEANING SOLUTIONS TO DRIVE THE SEGMENT GROWTH 54
TABLE 10 EXAMPLES OF COMPANIES PROVIDING TECHNOLOGY & INNOVATION IN HEALTHCARE EVS 54
6.5 FRONT-OF-HOUSE CLEANING AND BRAND EXPERIENCE 56
6.5.1 RISING AWARENESS TOWARDS A CLEAN AND SAFE ENVIRONMENT DURING PANDEMICS TO SUSTAIN THE MARKET GROWTH 56
6.6 OTHER SERVICES 56
 
7 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE 57
7.1 INTRODUCTION 58
FIGURE 19 STATES WITH THE HIGHEST NUMBER OF COVID-19 ADMISSIONS
(FEBRUARY 2022) 58
TABLE 11 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE, 2019–2026 (USD MILLION) 59
7.2 ACUTE-CARE FACILITIES 59
TABLE 12 US: HEALTHCARE ENVIRONMENTAL SERVICES FOR ACUTE-CARE SETTINGS, BY TYPE 2019–2026 (USD MILLION) 59
7.2.1 ACUTE HOSPITALS 60
7.2.1.1 Increasing hospital admissions due to COVID-19 and the rising prevalence of HAIs propel the market growth 60
FIGURE 20 NUMBER OF HAIS REPORTED BY GENERAL ACUTE CARE HOSPITALS
IN THE US (2020) 60
FIGURE 21 HAIS REPORTED BY GENERAL ACUTE CARE HOSPITALS IN THE US (2020) 61
FIGURE 22 HAIS REPORTED BY CRITICAL ACCESS HOSPITALS (CAHS) IN THE US (2018) 61
7.2.2 MILITARY TREATMENT FACILITY 61
7.2.2.1 The increasing number of military ambulatory health services & funding to drive the market growth 61
FIGURE 23 MILITARY HEALTH SYSTEMS FACILITIES IN THE US (2021) 62
7.2.3 CHILDREN’S HOSPITALS 62
7.2.3.1 Rising cases of COVID-19 and infection-related mortality rates among children drive the market growth 62
7.2.4 AMBULATORY SURGERY CENTERS (ASCS) 63
7.2.4.1 ASCs save time and reduce the risk of HAIS; key factor driving the market growth 63
FIGURE 24 US SURGERY CASES BY SETTING: ASC VS. HOPD (2005-2020) 64
7.2.5 ACADEMIC MEDICAL CENTERS (AMCS) 64
7.2.5.1 Healthcare capacity expansion during COVID-19 drives the adoption of healthcare environmental services in AMCs 64
7.3 POST-ACUTE CARE FACILITIES 64
TABLE 13 US: HEALTHCARE ENVIRONMENTAL SERVICES FOR POST-ACUTE CARE SETTINGS, BY TYPE 2019–2026 (USD MILLION) 65
7.3.1 LONG-TERM ACUTE HOSPITALS (LTACH) 65
7.3.1.1 Increasing risk of infection due to prolonged hospital stays to drive the market growth 65
7.3.2 SKILLED NURSING FACILITIES (SNF) 66
7.3.2.1 Increasing admissions of elderly people in skilled nursing facilities to drive the market growth 66
7.3.3 OTHER POST-ACUTE CARE FACILITIES 66
7.4 NON-ACUTE CARE FACILITIES 67
TABLE 14 US: ENVIRONMENTAL SERVICES MARKET FOR NON-ACUTE CARE SETTINGS, BY TYPE, 2019–2026 (USD MILLION) 67
7.4.1 PHYSICIAN’S OFFICES AND CLINICS 67
7.4.1.1 High patient traffic leads to continuous cleaning & maintenance to drive the market growth 67
7.4.2 OTHER NON-ACUTE CARE FACILITIES 68
FIGURE 25 DISTRIBUTION OF INDUSTRY MEDICAL AND HEALTH R&D INVESTMENTS,
BY SEGMENT (2020) 68
8 COMPETITIVE LANDSCAPE 70
8.1 OVERVIEW 70
8.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 70
8.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET 71
8.3 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS 72
8.4 MARKET RANKING ANALYSIS 73
FIGURE 27 US HEALTHCARE ENVIRONMENTAL SERVICE MARKET RANKING,
BY KEY PLAYER, 2020 73
8.5 COMPETITIVE BENCHMARKING 75
TABLE 15 FOOTPRINT OF COMPANIES IN THE HEALTHCARE ENVIRONMENTAL
SERVICES MARKET 75
TABLE 16 SERVICE FOOTPRINT OF COMPANIES 76
TABLE 17 END-USER FOOTPRINT OF COMPANIES 77
8.6 COMPETITIVE LEADERSHIP MAPPING 77
8.6.1 STARS 78
8.6.2 EMERGING LEADERS 78
8.6.3 PERVASIVE PLAYERS 78
8.6.4 PARTICIPANTS 78
FIGURE 28 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET:
COMPETITIVE LEADERSHIP MAPPING (2021) 79
8.7 COMPETITIVE SCENARIO 80
8.7.1 SERVICE APPROVALS/ENHANCEMENTS 80
8.7.2 DEALS 81
TABLE 19 DEALS, 2018–2022 81
8.7.3 OTHER DEVELOPMENTS 82
9 COMPANY PROFILES 83
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
9.1 SODEXO GLOBAL 83
TABLE 21 SODEXO GLOBAL: BUSINESS OVERVIEW 83
FIGURE 29 SODEXO GLOBAL: COMPANY SNAPSHOT (2021) 84
9.2 COMPASS GROUP (CROTHALL HEALTHCARE (US)) 87
TABLE 22 COMPASS GROUP: BUSINESS OVERVIEW 87
FIGURE 30 COMPASS GROUP: COMPANY SNAPSHOT (2021) 88
 
9.3 ARAMARK CORPORATION 90
TABLE 23 ARAMARK CORPORATION: BUSINESS OVERVIEW 90
FIGURE 31 ARAMARK CORPORATION: COMPANY SNAPSHOT (2021) 91
9.4 HOSPITAL HOUSEKEEPING SYSTEMS (HHS) (US) 94
TABLE 24 HOSPITAL HOUSEKEEPING SYSTEMS (HHS): BUSINESS OVERVIEW 94
9.5 HEALTHCARE SERVICES GROUP, INC. 97
TABLE 25 HEALTHCARE SERVICES GROUP, INC.: BUSINESS OVERVIEW 97
FIGURE 32 HEALTHCARE SERVICES GROUP: COMPANY SNAPSHOT (2020) 98
9.6 ABM INDUSTRIES INCORPORATED 100
TABLE 26 ABM INDUSTRIES INCORPORATED: BUSINESS OVERVIEW 100
FIGURE 33 ABM INDUSTRIES INCORPORATED: COMPANY SNAPSHOT (2020) 101
9.7 OCTOCLEAN 103
TABLE 27 OCTOCLEAN: BUSINESS OVERVIEW 103
9.8 SERVICEMASTER CLEAN (SERVICEMASTER TBS) 105
TABLE 28 SERVICEMASTER CLEAN.: BUSINESS OVERVIEW 105
9.9 CORVUS JANITORIAL SYSTEMS 107
TABLE 29 CORVUS JANITORIAL SYSTEMS: BUSINESS OVERVIEW 107
9.10 BRAVO! BUILDING SERVICES 109
TABLE 30 BRAVO! BUILDING SERVICES: BUSINESS OVERVIEW 109
9.11 POWERLINK ENVIRONMENTAL SERVICES, LLC 111
TABLE 31 POWERLINK ENVIRONMENTAL SERVICES, LLC: BUSINESS OVERVIEW 111
9.12 JANI-KING INTERNATIONAL, INC. 112
TABLE 32 JANI- KING INTERNATIONAL, INC: BUSINESS OVERVIEW 112
9.13 AVI FOOD SYSTEMS(US) 114
TABLE 33 AVI FOOD SYTEMS, INC.: BUSINESS OVERVIEW 114
9.14 SERVICON 115
TABLE 34 SERVICON: BUSINESS OVERVIEW 115
9.15 XANITOS, INC. 117
TABLE 35 XANITOS, INC.: BUSINESS OVERVIEW 117
9.16 STATHAKIS 119
TABLE 36 STATHAKIS: BUSINESS OVERVIEW 119
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
10 APPENDIX 120
10.1 INSIGHTS FROM INDUSTRY EXPERTS 120
10.2 DISCUSSION GUIDE 121
10.3 KNOWLEDGESTORE: MARKETSANDMARKETS SUBSCRIPTION PORTAL 124
10.4 AVAILABLE CUSTOMIZATIONS 126
10.5 RELATED REPORTS 126
10.6 AUTHOR DETAILS 127